200 related articles for article (PubMed ID: 30954448)
21. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
22. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
Potter LR
Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
[TBL] [Abstract][Full Text] [Related]
24. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population.
Doyle DD; Upshaw-Earley J; Bell EL; Palfrey HC
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2117-23. PubMed ID: 12003819
[TBL] [Abstract][Full Text] [Related]
25. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
26. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.
Beste KY; Spangler CM; Burhenne H; Koch KW; Shen Y; Tang WJ; Kaever V; Seifert R
PLoS One; 2013; 8(7):e70223. PubMed ID: 23922959
[TBL] [Abstract][Full Text] [Related]
27. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria.
Wen JF; Quan HX; Zhou GH; Cho KW
Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330
[TBL] [Abstract][Full Text] [Related]
28. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
29. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors.
Deschepper CF; Picard S
J Neurochem; 1994 May; 62(5):1974-82. PubMed ID: 7908948
[TBL] [Abstract][Full Text] [Related]
30. Guanylyl cyclase-B represents the predominant natriuretic peptide receptor expressed at exceptionally high levels in the pineal gland.
Müller D; Olcese J; Mukhopadhyay AK; Middendorff R
Brain Res Mol Brain Res; 2000 Feb; 75(2):321-9. PubMed ID: 10686354
[TBL] [Abstract][Full Text] [Related]
31. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
Telfer JF; Itoh H; Thomson AJ; Norman JE; Nakao K; Campa JS; Poston L; Tribe RM; Magness RR
J Clin Endocrinol Metab; 2001 Dec; 86(12):5934-43. PubMed ID: 11739467
[TBL] [Abstract][Full Text] [Related]
32. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Horio T; Tokudome T; Maki T; Yoshihara F; Suga S; Nishikimi T; Kojima M; Kawano Y; Kangawa K
Endocrinology; 2003 Jun; 144(6):2279-84. PubMed ID: 12746286
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes.
Su J; Scholz PM; Weiss HR
Exp Biol Med (Maywood); 2005 Apr; 230(4):242-50. PubMed ID: 15792945
[TBL] [Abstract][Full Text] [Related]
34. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.
Holditch SJ; Schreiber CA; Harris PC; LaRusso NF; Ramirez-Alvarado M; Cataliotti A; Torres VE; Ikeda Y
Kidney Int; 2017 Sep; 92(3):657-668. PubMed ID: 28416225
[TBL] [Abstract][Full Text] [Related]
36. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
37. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
[TBL] [Abstract][Full Text] [Related]
38. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
39. CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.
Martin FL; Sangaralingham SJ; Huntley BK; McKie PM; Ichiki T; Chen HH; Korinek J; Harders GE; Burnett JC
PLoS One; 2012; 7(12):e52422. PubMed ID: 23272242
[TBL] [Abstract][Full Text] [Related]
40. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
